eMed
Miami, Florida, United States · Health Care · 135 employees
eMed® is the world's first end-to-end GLP-1 care platform built on Empathetic AI™. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion.
Funding history
- Series series a — $200.0M — Mar 2026
Recent signals
- Mar 26, 2026: Raised $200.0M in Series series a
- Aug 05, 2025: eMed Population Health Appoints Linda Yaccarino as Chief Executive Officer
See plans & pricing → Track eMed ’s funding, hiring, and signals — with verified contacts — on Fundz.